Uracil nucleotide/cysteinyl leukotriene receptor Inhibitors (IC50, Ki)
Structure ▲ ▼ | Compound Name ▲ ▼ | Standard Type ▲ ▼ | Standard Values (in nM) ▲ ▼ |
3-(2-Carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid | Ki | 1210.0 [1], 2320.0 [2], 2450.0 [3] | |
Tryptophan | IC50 | 30000.0 [1] | |
Indomethacin | IC50 | 28800.0 [1] | |
5-Hydroxyindole-3-acetic acid | IC50 | 30000.0 [1] | |
Montelukast | Ki | 6540.0 [1] | |
Rizatriptan | IC50 | 30000.0 [1] | |
Pranlukast | Ki | 4060.0 [1] | |
Cangrelor tetrasodium | IC50 | 0.7 [1] | |
Azane;[(2R,3S,5R)-5-[6-(methylamino)purin-9-yl]-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate | IC50 | 508.0 [1] | |
2-Carboxy-6-methoxy-1H-indole-3-propionic acid | IC50 | 8400.0 [1] |
References
This online tool may be cited as follows
MLA | "Quest Database™ Uracil nucleotide/cysteinyl leukotriene receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/uracil-nucleotide-cysteinyl-leukotriene-receptor-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2024, November 21). Quest Database™ Uracil nucleotide/cysteinyl leukotriene receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/uracil-nucleotide-cysteinyl-leukotriene-receptor-inhibitors-ic50-ki. | |
BibTeX | EndNote | RefMan |